JP2025507962A - 炎症性腸疾患の治療のためのgpr120アゴニスト - Google Patents

炎症性腸疾患の治療のためのgpr120アゴニスト Download PDF

Info

Publication number
JP2025507962A
JP2025507962A JP2024552421A JP2024552421A JP2025507962A JP 2025507962 A JP2025507962 A JP 2025507962A JP 2024552421 A JP2024552421 A JP 2024552421A JP 2024552421 A JP2024552421 A JP 2024552421A JP 2025507962 A JP2025507962 A JP 2025507962A
Authority
JP
Japan
Prior art keywords
phenyl
gpr120
sulfamoyl
heptanoic acid
gpr120 agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024552421A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025507962A5 (cg-RX-API-DMAC7.html
Inventor
アレグレッティ,マルチェッロ
アラミーニ,アンドレア
ビアンキーニ,ジャンルカ
ダレッシオ,シルビア
シプリアーノ・ドゥトラ,ラファエル
Original Assignee
ドムペ・ファルマチェウティチ・ソチエタ・ペル・アツィオーニ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ドムペ・ファルマチェウティチ・ソチエタ・ペル・アツィオーニ filed Critical ドムペ・ファルマチェウティチ・ソチエタ・ペル・アツィオーニ
Publication of JP2025507962A publication Critical patent/JP2025507962A/ja
Publication of JP2025507962A5 publication Critical patent/JP2025507962A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024552421A 2022-03-03 2023-03-03 炎症性腸疾患の治療のためのgpr120アゴニスト Pending JP2025507962A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22160079.4 2022-03-03
EP22160079.4A EP4238557A1 (en) 2022-03-03 2022-03-03 Gpr120 agonists for the treatment of inflammatory bowel disease
PCT/EP2023/055490 WO2023166203A1 (en) 2022-03-03 2023-03-03 Gpr120 agonists for the treatment of inflammatory bowel disease

Publications (2)

Publication Number Publication Date
JP2025507962A true JP2025507962A (ja) 2025-03-21
JP2025507962A5 JP2025507962A5 (cg-RX-API-DMAC7.html) 2026-02-10

Family

ID=80628869

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024552421A Pending JP2025507962A (ja) 2022-03-03 2023-03-03 炎症性腸疾患の治療のためのgpr120アゴニスト

Country Status (7)

Country Link
US (1) US20250177329A1 (cg-RX-API-DMAC7.html)
EP (2) EP4238557A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025507962A (cg-RX-API-DMAC7.html)
CN (1) CN119031908A (cg-RX-API-DMAC7.html)
CA (1) CA3248186A1 (cg-RX-API-DMAC7.html)
IL (1) IL314689A (cg-RX-API-DMAC7.html)
WO (1) WO2023166203A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120919101A (zh) * 2025-09-26 2025-11-11 南京农业大学 Gw9508在制备治疗轮状病毒的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3281937A1 (en) * 2016-08-09 2018-02-14 Dompé farmaceutici S.p.A. Sulfonamides as gpr40- and gpr120-agonists
CN111317728A (zh) * 2018-12-14 2020-06-23 中国科学院大连化学物理研究所 天然来源ffa4(gpr120)受体激动剂及其应用

Also Published As

Publication number Publication date
EP4486327A1 (en) 2025-01-08
EP4238557A1 (en) 2023-09-06
WO2023166203A1 (en) 2023-09-07
CN119031908A (zh) 2024-11-26
CA3248186A1 (en) 2023-09-07
US20250177329A1 (en) 2025-06-05
IL314689A (en) 2024-10-01

Similar Documents

Publication Publication Date Title
TWI432201B (zh) 11-去氧基-前列腺素化合物用於治療週邊血管疾病之用途
AU2026200298A1 (en) Pharmaceutical use of an extended-release composition containing pirfenidone for the treatment and reversal of human steatohepatitis (nafld/nash)
JPH04504726A (ja) アナフィラキシーの遅反応性物質に対する拮抗薬としてのリポキシンa↓4およびその誘導体の使用
KR20210100594A (ko) 염증성 장애의 치료에 사용하기 위한 벤조이미다졸 유도체
WO2016112875A2 (zh) 二联苯衍生物及其应用
KR102694423B1 (ko) 신규한 글루타미닐 고리화효소 억제제 및 다양한 질환의 치료에서의 이의 용도
US20250177329A1 (en) Gpr120 agonists for the treatment of inflammatory bowel disease
JP2019077615A (ja) 非アルコール性脂肪性肝疾患/非アルコール性脂肪性肝炎の治療剤
SU1297865A1 (ru) Способ лечени больных хроническим неспецифическим звенным колитом
CN105147703B (zh) 黄柏酮在制备防治溃疡性结肠炎的药物中的应用
JPH1017478A (ja) 潰瘍性大腸炎の予防又は治療剤
JP2008509899A (ja) 胃腸管の炎症性疾患治療用の細胞特異的コンジュゲートの使用
CN105147661B (zh) 升麻素在制备防治溃疡性结肠炎的药物或食品中的应用
RU2829636C1 (ru) Фармацевтическая композиция на основе 5-пентилрезорцинола для лечения воспалительных заболеваний кишечника
CN105079012A (zh) 天麻素在制备防治溃疡性结肠炎的药物或食品中的应用
CN112107564A (zh) 五味子醇甲在制备防治溃疡性结肠炎的药物中的应用
CN111991387A (zh) 去氢二异丁香酚在制备防治溃疡性结肠炎的药物中的应用
BR112012000410B1 (pt) uso de benzidamina ou dos sais de adição de ácido, e, composição farmacêutica
JP5753435B2 (ja) 抗潰瘍剤組成物
FR3090317A1 (fr) Utilisation d’un antagoniste de par-1 pour le traitement d’une maladie inflammatoire chronique intestinale
RU2690372C2 (ru) Лекарственные средства, содержащие диацереин, и способы снижения уровней мочевой кислоты в крови с его использованием
CN119405649A (zh) 呋喃二烯酮在制备治疗炎症性肠病药物中的应用
JP6090723B2 (ja) 腎機能障害の予防又は改善剤
IT201900019858A1 (it) Composizione farmaceutica comprendente una combinazione sinergica di ibuprofene e N-acetilcisteina
WO2022006278A1 (en) Reducing fibrosis and treating related diseases, disorders, and conditions

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260202

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260202